References
- Lakoma A, Kim ES. Minimally invasive surgical management of benign breast lesions. Gland Surg. 2014;3(2):142–148.
- Ackerman LV, Mucciardi AN, Gose EE, et al. Classification of benign and malignant breast tumors on the basis of 36 radiographic properties. Cancer. 1973;31(2):342–352.
- Carty NJ, Carter C, Rubin C, et al. Management of fibroadenoma of the breast. Ann R Coll Surg Engl. 1995;77(2):127–130.
- Dixon JM. Conservative management of fibroadenoma of the breast. Br J Surg. 1996;83(12):1798–1799.
- Alle KM, Moss J, Venegas RJ, et al. Conservative management of fibroadenoma of the breast. Br J Surg. 1996;83(7):992–993.
- Jang JY, Kim SM, Kim JH, et al. Clinical significance of interval changes in breast lesions initially categorized as probably benign on breast ultrasound. Medicine (Baltimore). 2017;96(12):e6415
- Dyrstad SW, Yan Y, Fowler AM, et al. Breast cancer risk associated with benign breast disease: systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569–575.
- Orr B, Kelley JL, 3rd. Benign breast diseases: evaluation and management. Clin Obstet Gynecol. 2016;59(4):710–726.
- Jiang Y, Lan H, Ye Q, et al. Mammotome® biopsy system for the resection of breast lesions: Clinical experience in two high-volume teaching hospitals . Exp Ther Med. 2013;6(3):759–764.
- Pan S, Liu W, Jin K, et al. Ultrasound-guided vacuum-assisted breast biopsy using Mammotome biopsy system for detection of breast cancer: results from two high volume hospitals. Int J Clin Exp Med. 2014;7(1):239–246.
- Liberman L, Gougoutas CA, Zakowski MF, et al. Calcifications highly suggestive of malignancy: comparison of breast biopsy methods. AJR Am J Roentgenol. 2001;177(1):165–172.
- Li X, Fan WJ, Zhang L, et al. CT-guided percutaneous microwave ablation of liver metastases from nasopharyngeal carcinoma. J Vasc Interv Radiol. 2013;24(5):680–684.
- Liang P, Wang Y, Zhang D, et al. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J Urol. 2008;180(3):844–848; discussion 848.
- Wang Y, Liang P, Yu X, et al. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results. Int J Hyperthermia. 2009;25(6):455–461.
- Belfiore G, Ronza F, Belfiore MP, et al. Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82(1):177–181.
- Yue W, Wang S, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol. 2013;82(1):e11–e16.
- Yu J, Chen BH, Zhang J, et al. Ultrasound guided percutaneous microwave ablation of benign breast lesions. Oncotarget. 2017;8(45):79376–79386.
- Zhang W, Jin ZQ, Baikpour M, et al. Clinical application of ultrasound-guided percutaneous microwave ablation for benign breast lesions: a prospective study. BMC Cancer . 2019;19(1):345
- Zhou W, Wang R, Liu X, et al. Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours. Int J Hyperthermia. 2017;33(3):263–270.
- Zhang W, Li JM, He W, et al. Ultrasound-guided percutaneous microwave ablation for benign breast lesions: evaluated by contrast-enhanced ultrasound combined with magnetic resonance imaging. J Thorac Dis. 2017;9(11):4767–4773.
- Xu J, Wu H, Han Z, et al. Microwave ablation of benign breast tumors: a prospective study with minimum 12 months follow-up. Int J Hyperthermia. 2018;35(1):253–261.
- Li C, Ge H, Liang M, et al. Technical analysis of US imaging for precise microwave ablation for benign breast tumours. Int J Hyperthermia. 2018;34(8):1179–1185.
- Carrafiello G, Ierardi AM, Fontana F, et al. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol. 2013;24(10):1513–1520.
- Li W, Ye X, Yang X, et al. Microwave ablation as palliative treatment of locally recurrent colorectal cancer. Indian J Cancer. 2015;52(6):e61-63.
- Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. Int J Hyperthermia. 2014;30(2):150–157.
- Goldberg J, McCrosson S, Kaulback KR. Delayed leiomyoma degeneration after microwave endometrial ablation. Obstet Gynecol. 2005;106(5 Pt 2):1176–1178.
- Cheng Z, Liang P, Yu X, et al. Percutaneous microwave ablation for benign focal liver lesions: Initial clinical results. Oncol Lett. 2017;13(1):429–434.
- Todorova VK, Klimberg VS, Hennings L, et al. Immunomodulatory effects of radiofrequency ablation in a breast cancer model. Immunol Invest. 2010;39(1):74–92.
- Widenmeyer M, Shebzukhov Y, Haen SP, et al. Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation. Int J Cancer. 2011;128(11):2653–2662.
- Zhou W, Jiang Y, Chen L, et al. Image and pathological changes after microwave ablation of breast cancer: a pilot study. Eur J Radiol. 2014;83(10):1771–1777.
- Peek MCL, Douek M. Ablative techniques for the treatment of benign and malignant breast tumours. J Ther Ultrasound. 2017;5:18
- Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
- Baek JH, Lee JH, Sung JY, Korean Society of Thyroid Radiology, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342.